Annual ROE
801.89%
+1027.36%+455.65%
December 31, 2023
Summary
- As of March 7, 2025, UNCY annual return on equity is 801.89%, with the most recent change of +1027.36% (+455.65%) on December 31, 2023.
- During the last 3 years, UNCY annual ROE has risen by +717.13% (+846.07%).
- UNCY annual ROE is now at all-time high.
Performance
UNCY ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-119.32%
+57.08%+32.36%
September 30, 2024
Summary
- As of March 7, 2025, UNCY quarterly return on equity is -119.32%, with the most recent change of +57.08% (+32.36%) on September 30, 2024.
- Over the past year, UNCY quarterly ROE has increased by +600.55% (+83.42%).
- UNCY quarterly ROE is now -212.09% below its all-time high of 106.45%, reached on June 30, 2021.
Performance
UNCY Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
UNCY ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +455.6% | +83.4% |
| 3 y3 years | +846.1% | +83.4% |
| 5 y5 years | +227.4% | +83.4% |
UNCY ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +455.6% | -15.6% | +83.4% |
| 5 y | 5-year | at high | +455.6% | -212.1% | +83.4% |
| alltime | all time | at high | +455.6% | -212.1% | +83.4% |
Unicycive Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -119.32%(-32.4%) |
| Jun 2024 | - | -176.40%(-66.3%) |
| Mar 2024 | - | -524.12%(-27.2%) |
| Dec 2023 | 801.89%(-455.7%) | -719.87%(+30.2%) |
| Sep 2023 | - | -552.77%(+1.4%) |
| Jun 2023 | - | -544.90%(+15.1%) |
| Mar 2023 | - | -473.36%(+79.0%) |
| Dec 2022 | -225.47% | -264.45%(+89.0%) |
| Sep 2022 | - | -139.91%(+35.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | -103.19%(-8.8%) |
| Mar 2022 | - | -113.11%(-21.3%) |
| Dec 2021 | -60.77%(-171.7%) | -143.73%(-61.5%) |
| Sep 2021 | - | -373.54%(-450.9%) |
| Jun 2021 | - | 106.45%(+12.1%) |
| Mar 2021 | - | 94.98%(+12.1%) |
| Dec 2020 | 84.76%(-65.4%) | - |
| Dec 2020 | - | 84.76% |
| Dec 2019 | 244.91% | - |
FAQ
- What is Unicycive Therapeutics annual return on equity?
- What is the all time high annual ROE for Unicycive Therapeutics?
- What is Unicycive Therapeutics annual ROE year-on-year change?
- What is Unicycive Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Unicycive Therapeutics?
- What is Unicycive Therapeutics quarterly ROE year-on-year change?
What is Unicycive Therapeutics annual return on equity?
The current annual ROE of UNCY is 801.89%
What is the all time high annual ROE for Unicycive Therapeutics?
Unicycive Therapeutics all-time high annual return on equity is 801.89%
What is Unicycive Therapeutics annual ROE year-on-year change?
Over the past year, UNCY annual return on equity has changed by +1027.36% (+455.65%)
What is Unicycive Therapeutics quarterly return on equity?
The current quarterly ROE of UNCY is -119.32%
What is the all time high quarterly ROE for Unicycive Therapeutics?
Unicycive Therapeutics all-time high quarterly return on equity is 106.45%
What is Unicycive Therapeutics quarterly ROE year-on-year change?
Over the past year, UNCY quarterly return on equity has changed by +600.55% (+83.42%)